Label: BISMUSAL- bismuth subsalicylate suspension
- NDC Code(s): 58005-700-07
- Packager: Sparhawk Laboratories, Inc.
- Category: OTC ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated October 11, 2017
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- INDICATIONS & USAGE
- CONTRAINDICATION
- CAUTION
-
DOSAGE AND ADMINISTRATION
Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.
Dogs- 1 to 3 tablespoons
Calves- 3 to 4 ounces
Foals- 3 to 4 ounces
Cattle and Horses- 6-10 fl. ozs.
This product may cause stools to darken. If diarrhea persists after using this product for 2 days, contact veterinarian.
- COMPOSITION
- STORAGE AND HANDLING
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
BISMUSAL
bismuth subsalicylate suspensionProduct Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:58005-700 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (BISMUTH CATION - UNII:ZS9CD1I8YE) BISMUTH SUBSALICYLATE 66.2 g in 3.785 L Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58005-700-07 3.785 L in 1 JUG Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/18/2009 Labeler - Sparhawk Laboratories, Inc. (147979082)
